Mónica MartÃnez Cengotitabengoa
HOSPITAL UNIVERSITARIO DE ALAVA-SEDE SANTIAGO
Sant Pau Biomedical Research Institute
Spain
Biography
DOCUMENT "CUM LAUDE" IN PHARMACY (Feb-2000): doctoral thesis conducted in the Department of Preventive Medicine and Public Health of the University of the Basque Country and titled "Adverse Reactions to Medications in Hospitalized Elderly". CERTIFICATE OF PEDAGOGICAL FITNESS (2000-2001): Universidad Complutense de Madrid. Didactics of Natural Sciences. MASTER IN COMMUNITY PHARMACEUTICAL CARE (2007). Valencia's university. POSTGRADUATE of "Informational skills in health sciences" of the Uinivesidad Abierta de Catalunya (2008). Currently attending the "Master in Drug Safety: pharmacovigilance and post-authorization studies" of the University of Seville Associate Professor in the Department of Pharmacy, Nutrition, Technology and Animal Production of the Faculty of Pharmacy of Vitoria (UPV - Oxidative stress in early onset psychotic episodes - Analysis of risk polymorphisms in wide-ranging association studies in psychosis (GWAS) - Double-blind, placebo-controlled clinical trial of the efficacy of reboxetine and citalopram as an adjunctive treatment for antipsychotics of second generation in the treatment of the negative symptoms of schizophrenia - Pragmatic, parallel and randomized clinical trial with masked evaluation of therapeutic strategies in the fret or major depressive resistant to treatment with SSRIs. He has presented 3 communications to congresses. Professional profile parallel and randomized trial with masked evaluation of therapeutic strategies in the elderly or major depressive resistant to treatment with SSRIs. He has presented 3 communications to congresses. Professional profile parallel and randomized trial with masked evaluation of therapeutic strategies in the elderly or major depressive resistant to treatment with SSRIs. He has presented 3 communications to congresses. Professional profile
Research Interest
Preventive Medicine and Public Health
Publications
-
MartÃnez-Cengotitabengoa M1, Micó JA2, Arango C3, Castro-Fornieles J4, Graell M5, Payá B6, Leza JC7, Zorrilla I8, Parellada M9, López MP10, Baeza I11, Moreno C9, Rapado-Castro M9, González-Pinto A10. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study. Schizophr Res. 2014 Jun;156(1):23-9.
-
Fernández-Atucha A1, EchevarrÃa E2, Larrinaga G3, Gil J4, MartÃnez-Cengotitabengoa M5, González-Pinto AM6, Irazusta J7, Seco J8. Plasma peptidases as prognostic biomarkers in patients with first-episode psychosis. Psychiatry Res. 2015 Aug 15;228(2):197-202.